JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 24, 2008; DOI: 10.1124/jpet.107.134296


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.134296v1
325/1/319    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lane, J. R.
Right arrow Articles by Milligan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lane, J. R.
Right arrow Articles by Milligan, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference


Received for publication November 26, 2007.
Revised January 23, 2008.
Accepted for publication January 23, 2008.

G protein-coupling and ligand selectivity of the D2L and D3 dopamine receptors

J. Robert Lane 1, Ben Powney 2, Alan Wise 2, Stephen Rees 2, Graeme Milligan 1*

1 University of Glasgow 2 GlaxoSmithKline

* Address correspondence to: E-mail: g.milligan{at}bio.gla.ac.uk

Abstract

The human dopamine D2L receptor couples promiscuously to multiple members of the G{alpha}i/o subfamily. Despite the high homology of the D2L and D3 receptors, the G protein-coupling specificity of the human D3 receptor is less clearly characterized. The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors. By employing both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual G{alpha}i-family G proteins were expressed in an inducible fashion we demonstrated highly selective coupling of the D3 receptor to G{alpha}o1. Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to G{alpha}o1 as compared to the D2L receptor. The second aim of this study was to investigate the molecular basis of the above differential G protein-coupling specificity. The importance of a twelve amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equivalent region of the D3 receptor was exchanged for this sequence. This chimera displayed D3-like affinity for [3H] spiperone and potency for agonists, but gained D2-like ability to couple to each of G{alpha}i1-3 as well as G{alpha}o1.


Key words: G protein coupled receptors, G proteins, antipsychotic drugs, dopamine, functional selectivity, signal transduction





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.